All In Biotech

Drug Trial Radar · NCT07501559

A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)

Last checked: Nov 20, 2026Latest source record: Aug 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

40

Planned (sponsor's estimate)

Start

Jun 17, 2026

Primary completion

Apr 2030

Study completion Apr 2030

Sponsor

Sponsor type
Industry
First posted
Mar 30, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to evaluate the safety and efficacy of JL15003 Injection in subjects with recurrent glioblastoma (rGMB).

Conditions

  • Recurrent Glioblastoma Multiforme(GBM)

Interventions

  • JL15003InjectionBiological

    Intratumoral or intracavitary administration of JL15003 Injection as needed

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Any changes in the incidence and severity of Adverse Events (AEs)Time frame: From the signing of the informed consent by the first subject to the end of the study,up to 15 years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Huashan Hospital, Shanghai Medical College, Fudan University & Beijing TianTan Hospital,Capital Medical University

    Shanghai, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.